SH3GL2 and head and neck squamous cell carcinoma: It was evident that 80% (20/25) primary HNSCC samples showed ≥2 fold reduction of SH3GL2 mRNA expression with 6.4 (±13.5632) mean fold reduction (Figure 3g).